pentobarbital has been researched along with Bronchopulmonary Dysplasia in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joss-Moore, LA | 1 |
Hagen-Lillevik, SJ | 1 |
Yost, C | 1 |
Jewell, J | 1 |
Wilkinson, RD | 1 |
Bowen, S | 1 |
Dahl, MJ | 1 |
Dong, L | 1 |
Wang, Z | 1 |
Presson, AP | 1 |
Zhang, C | 1 |
Null, DM | 1 |
Yoder, BA | 1 |
Albertine, KH | 1 |
1 other study available for pentobarbital and Bronchopulmonary Dysplasia
Article | Year |
---|---|
Alveolar formation is dysregulated by restricted nutrition but not excess sedation in preterm lambs managed by noninvasive support.
Topics: Animal Nutritional Physiological Phenomena; Animals; Animals, Newborn; Apoptosis; Bronchopulmonary D | 2016 |